Mr. Jeff Wells has over 25 years of CMC-related experience in vaccines, gene therapy, pharmaceuticals, and the medical devices industry. His functional experience ranges from development and day-to-day management of QA/QC operations to remediating quality systems at firms of various sizes. Mr. Wells has held various quality management positions at Baxter Healthcare Corp and other emerging biotechnology companies. He specializes in developing and deploying quality systems required to support commercialization of new products, manage compliant and efficient operations, and remediate significant regulatory compliance deficiencies. Over half of his career has been spent directly or indirectly overseeing Quality activities in firms developing products such as AAV-based gene therapy candidates to several vaccines for polio, smallpox, anthrax, and pandemic influenza.